Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases

Journal of Hepatology

Volumn 61, Issue 1, 2014, Pages S69-S78

  Negro, Francesco ^a  

^a University Hospital   (Switzerland)

Author keywords

Atherosclerosis; Coronary artery disease; Diabetes; Hepatitis C virus; Insulin resistance; Steatosis; Stroke.

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; FATTY LIVER; GLUCOSE HOMEOSTASIS; HEPATITIS C; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; STEATOSIS; VIRUS REPLICATION; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; PROGNOSIS; RISK FACTOR;

CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FATTY LIVER; HEPATITIS C; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 84913535452     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.003     Document Type: Review

References (132)

1. B. Hajarizadeh, J. Grebely, and G.J. Dore Epidemiology and natural history of HCV infection Nat Rev Gastroenterol Hepatol 10 2013 553 562
2. Cowie BC, Allard N, MacLachlan JH. European responses in focus: comparing viral hepatitis and HIV related deaths in Europe 1990-201 in the Global Burden of Disease Study 2010. In: 49th Annual meeting of the European Association for the Study of the Liver, London; 2014, abstract #86.
3. K.N. Ly, J. Xing, R.M. Klevens, R.B. Jiles, J.W. Ward, and S.D. Holmberg The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007 Ann Intern Med 156 2012 271 278
4. H. Razavi, I. Waked, C. Sarrazin, R.P. Myers, R. Idilman, and F. Calinas The present and future disease burden of hepatitis C virus with today's treatment paradigm J Viral Hepat 21 2014 34 59
5. G.L. Armstrong, M.J. Alter, G.M. McQuillan, and H.S. Margolis The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States Hepatology 31 2000 777 782
6. I.M. Jacobson, P. Cacoub, L. Dal Maso, S.A. Harrison, and Z.M. Younossi Manifestations of chronic hepatitis C virus infection beyond the liver Clin Gastroenterol Hepatol 8 2010 1017 1029
7. E. Bugianesi, F. Salamone, and F. Negro The interaction of metabolic factors with HCV infection: does it matter? J Hepatol 56 2012 S56 S65
8. L. Rubbia-Brandt, R. Quadri, K. Abid, E. Giostra, J.P. Zarski, and L. Spahr Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 J Hepatol 33 2000 106 115
9. L.E. Adinolfi, L. Restivo, R. Zampino, B. Guerrera, A. Lonardo, and L. Ruggiero Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis Atherosclerosis 221 2012 496 502
10. N. Goossens, and F. Negro Is the genotype 3 of the hepatitis C virus the new villain? Hepatology 59 2014 2403 2412
11. G. Leandro, A. Mangia, J. Hui, P. Fabris, L. Rubbia-Brandt, and G. Colloredo The relationship between hepatic steatosis, inflammation and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 2006 1636 1642
12. L. Rubbia-Brandt, E. Giostra, G. Mentha, R. Quadri, and F. Negro Expression of liver steatosis in hepatitis C virus infection and pattern of response to α-interferon J Hepatol 35 2001 307
13. F. Negro Abnormalities of lipid metabolism in hepatitis C virus infection Gut 59 2010 1279 1287
14. G. Waris, D.J. Felmlee, F. Negro, and A. Siddiqui Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress J Virol 81 2007 8122 8130
15. J.K. Oem, C. Jackel-Cram, Y.P. Li, Y. Zhou, J. Zhong, and H. Shimano Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2 J Gen Virol 89 2008 1225 1230
16. C.Y. Park, H.J. Jun, T. Wakita, J.H. Cheong, and S.B. Hwang Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway J Biol Chem 284 2009 9237 9246
17. C. Jackel-Cram, L. Qiao, Z. Xiang, R. Brownlie, Y. Zhou, and L. Babiuk Hepatitis C virus genotype-3a core protein enhances sterol regulatory element-binding protein-1 activity through the phosphoinositide 3-kinase-Akt-2 pathway J Gen Virol 91 2010 1388 1395
18. Z. Xiang, L. Qiao, Y. Zhou, L.A. Babiuk, and Q. Liu Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1 Biochem Biophys Res Commun 402 2010 549 553
19. S. McPherson, J.R. Jonsson, H.D. Barrie, P. O'Rourke, A.D. Clouston, and E.E. Powell Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis J Hepatol 49 2008 1046 1054
20. P.Y. Bochud, T. Cai, K. Overbeck, M. Bochud, M. Rickenbach, and J.F. Dufour Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C J Hepatol 51 2009 655 666
21. F. Kanwal, J.R. Kramer, J. Ilyas, Z. Duan, and H.B. El-Serag HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV Hepatology 60 2014 98 105
22. D. Kumar, G.C. Farrell, C. Fung, and J. George Hepatitis C virus genotype 3 is cytopathic to hepatocytes. Genotype-specific reversal of hepatic steatosis after sustained response to antiviral therapy Hepatology 36 2002 1266 1272
23. T. Poynard, V. Ratziu, J. McHutchison, M. Manns, Z. Goodman, and S. Zeuzem Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C Hepatology 38 2003 75 85
24. L.E. Adinolfi, M. Gambardella, A. Andreana, M.F. Tripodi, R. Utili, and G. Ruggiero Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 2001 1358 1364
25. L. Fartoux, O. Chazouillères, D. Wendum, R. Poupon, and L. Serfaty Impact of steatosis on progression of fibrosis in patients with mild hepatitis C Hepatology 41 2005 82 87
26. K. Ohata, K. Hamasaki, K. Toriyama, K. Matsumoto, A. Saeki, and K. Yanagi Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection Cancer 97 2003 3036 3043
27. J.R. Pekow, A.K. Bhan, H. Zheng, and R.T. Chung Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis Cancer 109 2007 2490 2496
28. M. Kurosaki, T. Hosokawa, K. Matsunaga, I. Hirayama, T. Tanaka, and M. Sato Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage, and response to interferon therapy Hepatol Res 40 2010 870 877
29. E.E. Calle, M.J. Thun, J.M. Petrelli, C. Rodriguez, and C.W. Heath Jr. Body-mass index and mortality in a prospective cohort of U.S. adults N Engl J Med 341 1999 1097 1105
30. G. Nkontchou, M. Ziol, M. Aout, M. Lhabadie, Y. Baazia, and A. Mahmoudi HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis J Viral Hepat 18 2011 e516 e522
31. A.J. van der Meer, B.J. Veldt, J.J. Feld, H. Wedemeyer, J.F. Dufour, and F. Lammert Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis JAMA 308 2012 2584 2593
32. L. Rubbia-Brandt, P. Fabris, S. Paganin, G. Leandro, P.J. Male, and E. Giostra Steatosis affects chronic hepatitis C progression in a genotype-specific way Gut 53 2004 406 412
33. E.E. Powell, W.G. Cooksley, and R. Hanson The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
34. A. Poonawala, S.P. Nair, and P.J. Thuluvath Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 32 2000 689 692
35. A.V. Ivanov, B. Bartosch, O.A. Smirnova, M.G. Isaguliants, and S.N. Kochetkov HCV and oxidative stress in the liver Viruses 5 2013 439 469
36. S. Clément, M. Peyrou, A. Sanchez-Pareja, L. Bourgoin, P. Ramadori, and D.M. Suter Downregulation of PTEN and IRS1 by HCV core protein 3a triggers steatosis in hepatocytes Hepatology 54 2011 38 49
37. H. Hofer, H.C. Bankl, F. Wrba, P. Steindl-Munda, M. Peck-Radosavljevic, and C. Osterreicher Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a Am J Gastroenterol 97 2002 2880 2885
38. K.E. Corey, E. Kane, C. Munroe, L.L. Barlow, H. Zheng, and R.T. Chung Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up Hepatology 50 2009 1030 1037
39. P. Bedossa, R. Moucari, E. Chelbi, T. Asselah, V. Paradis, and M. Vidaud Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study Hepatology 46 2007 380 387
40. D.L. White, V. Ratziu, and H.B. El-Serag Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis J Hepatol 49 2008 831 844
41. S.H. Mehta, F.L. Brancati, M.S. Sulkowski, S.A. Strathdee, M. Szklo, and D.L. Thomas Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States Ann Intern Med 133 2000 592 599
42. S.H. Mehta, F.L. Brancati, S.A. Strathdee, J.S. Pankow, D. Netski, and J. Coresh Hepatitis C virus infection and incident type 2 diabetes Hepatology 38 2003 50 56
43. M. Khalili, J.W. Lim, N. Bass, N.L. Ascher, J.P. Roberts, and N.A. Terrault New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection Liver Transpl 10 2004 349 355
44. A. Delgado-Borrego, Y.S. Liu, S.H. Jordan, S. Agrawal, H. Zhang, and M. Christofi Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance Liver Transpl 14 2008 193 201
45. T. Chen, H. Jia, J. Li, X. Chen, H. Zhou, and H. Tian New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies Transpl Int 22 2009 408 415
46. N. Kamar, C. Mariat, M. Delahousse, J. Dantal, A. Al Najjar, and E. Cassuto Diabetes mellitus after kidney transplantation: a French multicentre observational study Nephrol Dial Transplant 22 2007 1986 1993
47. F. Fabrizi, P. Messa, P. Martin, and B. Takkouche Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: a meta-analysis Int J Artif Organs 31 2008 675 682
48. S. Rudoni, J.M. Petit, J.B. Bour, L.S. Aho, A. Castaneda, and G. Vaillant HCV infection and diabetes mellitus: influence of the use of finger stick devices on nosocomial transmission Diabetes Metab 25 1999 502 505
49. J.M. Hui, A. Sud, G.C. Farrell, P. Bandara, K. Byth, and J.G. Kench Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression Gastroenterology 125 2003 1695 1704
50. R. Moucari, T. Asselah, D. Cazals-Hatem, H. Voitot, N. Boyer, and M.P. Ripault Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis Gastroenterology 134 2008 416 423
51. M. Romero-Gómez, M. Del Mar Viloria, R.J. Andrade, J. Salmerón, M. Diago, and C.M. Fernández-Rodríguez Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients Gastroenterology 128 2005 636 641
52. N.A. Mukhtar, P. Bacchetti, C.E. Ayala, J. Melgar, S. Christensen, and J.J. Maher Insulin sensitivity and variability in hepatitis C virus infection using direct measurement Dig Dis Sci 58 2013 1141 1148
53. G. Fattovich, G.S. Baroni, M. Pasino, I. Pierantonelli, L. Covolo, and D. Ieluzzi Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome Dig Liver Dis 44 2012 419 425
54. E. Vanni, M.L. Abate, E. Gentilcore, I. Hickman, R. Gambino, and M. Cassader Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C Hepatology 50 2009 697 706
55. K.L. Milner, D. van der Poorten, M. Trenell, A.B. Jenkins, A. Xu, and G. Smythe Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance Gastroenterology 138 2010 e931 e933
56. V. Kaddai, and F. Negro Current understanding of insulin resistance in hepatitis C Expert Rev Gastroenterol Hepatol 5 2011 503 516
57. S. Aytug, D. Reich, L.E. Sapiro, D. Bernstein, and N. Begum Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes Hepatology 38 2003 1384 1392
58. Y. He, H. Nakao, S.L. Tan, S.J. Polyak, P. Neddermann, and S. Vijaysri Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase J Virol 76 2002 9207 9217
59. A. Street, A. Macdonald, K. Crowder, and M. Harris The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade J Biol Chem 279 2004 12232 12241
60. P. Mannová, and L. Beretta Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication J Virol 79 2005 8742 8749
61. Y.C. Hsu, J.T. Lin, H.J. Ho, Y.H. Kao, Y.T. Huang, and N.W. Hsiao Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients Hepatology 59 2014 1293 1302
62. J. Massard, V. Ratziu, D. Thabut, J. Moussalli, P. Lebray, and Y. Benhamou Natural history and predictors of disease severity in chronic hepatitis C J Hepatol 44 2006 S19 S24
63. A. Muzzi, L. Rubbia-Brandt, G. Leandro, R. James, O. Keiser, and R. Malinverni Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients J Hepatol 42 2005 39 44
64. E. Bugianesi, G. Marchesini, E. Gentilcore, I.H. Cua, E. Vanni, and M. Rizzetto Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis Hepatology 44 2006 1648 1655
65. G. Svegliati-Baroni, E. Bugianesi, T. Bouserhal, F. Marini, F. Ridolfi, and F. Tarsetti Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease Gut 56 2007 1296 1301
66. V. Paradis, G. Perlemuter, F. Bonvoust, D. Dargere, B. Parfait, and M. Vidaud High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis Hepatology 34 2001 738 744
67. G. Svegliati-Baroni, F. Ridolfi, A. Di Sario, A. Casini, L. Marucci, and G. Gaggiotti Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways Hepatology 29 1999 1743 1751
68. R. Cancello, J. Tordjman, C. Poitou, G. Guilhem, J.L. Bouillot, and D. Hugol Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity Diabetes 55 2006 1554 1561
69. F. Marra, R. DeFranco, C. Grappone, S. Milani, S. Pastacaldi, and M. Pinzani Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration Am J Pathol 152 1998 423 430
70. S. Clement, C. Juge-Aubry, S. Conzelmann, V. Pazienza, B. Pittet-Cuenod, and C. Meier Monocyte chemoattractant protein-1 secreted by adipose tissue induce lipid accumulation in hepatocytes Hepatology 48 2008 799 807
71. K. Miura, L. Yang, N. van Rooijen, H. Ohnishi, and E. Seki Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2 Am J Physiol 302 2012 G1310 G1321
72. E. Seki, S. de Minicis, S. Inokuchi, K. Taura, K. Miyai, and N. van Rooijen CCR2 promotes hepatic fibrosis in mice Hepatology 50 2009 185 197
73. P. Farci, K. Wollenberg, G. Diaz, R.E. Engle, M.E. Lai, and P. Klenerman Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis Proc Natl Acad Sci U S A 109 2012 14562 14567
74. M. Khattab, M. Eslam, M.A. Sharwae, M. Shatat, A. Ali, and L. Hamdy Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients Am J Gastroenterol 105 2010 1970 1977
75. M. Eslam, R. Aparcero, T. Kawaguchi, J.A. Del Campo, M. Sata, and M.A. Khattab Meta-analysis: insulin resistance and sustained virological response in hepatitis C Aliment Pharmacol Ther 34 2011 297 305
76. Y. Saad, A. Ahmed, D.A. Saleh, and W. Doss Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4 Eur J Gastroenterol Hepatol 25 2013 920 925
77. S.A. Harrison, F.M. Hamzeh, J. Han, P.K. Pandya, M.Y. Sheikh, and J.M. Vierling Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin Hepatology 56 2012 464 473
78. M. Romero-Gómez, M. Diago, R.J. Andrade, J.L. Calleja, J. Salmerón, and C.M. Fernández-Rodríguez Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin Hepatology 50 2009 1702 1708
79. L. Serfaty, X. Forns, T. Goeser, P. Ferenci, F. Nevens, and G. Carosi Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1 Gut 61 2012 1473 1480
80. Z. Younossi, F. Negro, L. Serfaty, S. Pol, M. Diago, and S. Zeuzem Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial Hepatology 58 2013 1897 1906
81. R. Moucari, N. Forestier, D. Larrey, D. Guyader, P. Couzigou, and Y. Benhamou Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in genotype 1 chronic hepatitis C patients Gut 59 2010 1694 1698
82. B.J. Veldt, W. Chen, E.J. Heathcote, H. Wedemeyer, J. Reichen, and W.P. Hofmann Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus Hepatology 47 2008 1856 1862
83. Y. Arase, M. Kobayashi, F. Suzuki, Y. Suzuki, Y. Kawamura, and N. Akuta Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C Hepatology 57 2013 964 973
84. C. Giordanino, E. Bugianesi, A. Smedile, A. Ciancio, M.L. Abate, and A. Olivero Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study Am J Gastroenterol 103 2008 2481 2487
85. A. Aghemo, G.M. Prati, M.G. Rumi, R. Soffredini, R. D'Ambrosio, and E. Orsi Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C Hepatology 56 2012 1681 1687
86. M. Romero-Gómez, C.M. Fernández-Rodríguez, R.J. Andrade, M. Diago, S. Alonso, and R. Planas Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C J Hepatol 48 2008 721 727
87. Y. Arase, F. Suzuki, Y. Suzuki, N. Akuta, M. Kobayashi, and Y. Kawamura Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C Hepatology 49 2009 739 744
88. I. Konishi, Y. Hiasa, Y. Tokumoto, M. Abe, S. Furukawa, and K. Toshimitsu Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus Hepatol Res 41 2011 928 935
89. A. St George, A. Bauman, A. Johnston, G. Farrell, T. Chey, and J. George Independent effects of physical activity in patients with nonalcoholic fatty liver disease Hepatology 50 2009 68 76
90. I.J. Hickman, A.D. Clouston, G.A. Macdonald, D.M. Purdie, J.B. Prins, and S. Ash Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C Gut 51 2002 89 94
91. Z.J. Zhang, Z.J. Zheng, R. Shi, Q. Su, Q. Jiang, and K.E. Kip Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis J Clin Endocrinol Metab 97 2012 2347 2353
92. S. Singh, P.P. Singh, A.G. Singh, M.H. Murad, and W. Sanchez Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis Am J Gastroenterol 108 2013 881 891
93. H. Zhang, C. Gao, L. Fang, H.C. Zhao, and S.K. Yao Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis Scand J Gastroenterol 48 2013 78 87
94. H.P. Chen, J.J. Shieh, C.C. Chang, T.T. Chen, J.T. Lin, and M.S. Wu Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies Gut 62 2013 606 615
95. S. Kiechl, G. Egger, M. Mayr, C.J. Wiedermann, E. Bonora, and F. Oberhollenzer Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study Circulation 103 2001 1064 1070
96. J. Zhu, A.A. Quyyumi, J.E. Norman, R. Costello, G. Csako, and S.E. Epstein The possible role of hepatitis A virus in the pathogenesis of atherosclerosis J Infect Dis 182 2000 1583 1587
97. N. Ishizaka, Y. Ishizaka, E. Takahashi, Tooda Ei, H. Hashimoto, and R. Nagai Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening Lancet 359 2002 133 135
98. Y. Ishizaka, N. Ishizaka, E. Takahashi, T. Unuma, E. Tooda, and H. Hashimoto Association between hepatitis C virus core protein and carotid atherosclerosis Circ J 67 2003 26 30
99. H. Tomiyama, T. Arai, K. Hirose, S. Hori, Y. Yamamoto, and A. Yamashina Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity Atherosclerosis 166 2003 401 403
100. G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Arcaro, and C. Day Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C J Hepatol 46 2007 1126 1132
101. C.F. Jan, C.J. Chen, Y.H. Chiu, L.S. Chen, H.M. Wu, and C.C. Huang A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10) Int J Obes (Lond) 30 2006 794 799
102. B. Luo, Y. Wang, and K. Wang Association of metabolic syndrome and hepatitis B infection in a Chinese population Clin Chim Acta 380 2007 238 240
103. S. Petta, D. Torres, G. Fazio, C. Cammà, D. Cabibi, and V. Di Marco Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations Hepatology 55 2012 1317 1323
104. P.C. Tien, M.F. Schneider, S.R. Cole, M.H. Cohen, M.J. Glesby, and J. Lazar Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study AIDS 23 2009 1781 1784
105. M. Masiá, S. Padilla, C. Robledano, J.M. Ramos, and F. Gutiérrez Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study BMC Infect Dis 11 2011 265
106. P. Sosner, M. Wangermez, C. Chagneau-Derrode, G. Le Moal, and C. Silvain Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection Atherosclerosis 222 2012 274 277
107. C. Vassalle, S. Masini, F. Bianchi, and G.C. Zucchelli Evidence for association between hepatitis C virus seropositivity and coronary artery disease Heart 90 2004 565 566
108. O. Alyan, F. Kacmaz, O. Ozdemir, B. Deveci, R. Astan, and A.S. Celebi Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system Circ J 72 2008 1960 1965
109. D. Marelli, J. Bresson, H. Laks, B. Kubak, G. Fonarow, and F.C. Tsai Hepatitis C-positive donors in heart transplantation Am J Transplant 2 2002 443 447
110. S.A. Haji, R.C. Starling, R.K. Avery, S. Mawhorter, E.M. Tuzcu, and P. Schoenhagen Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation J Heart Lung Transplant 23 2004 277 283
111. Z.M. Younossi, W.E. Braun, D.A. Protiva, R.W. Gifford Jr., and R.A. Straffon Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years Transplantation 67 1999 272 275
112. A.A. Butt, W. Xiaoqiang, M. Budoff, D. Leaf, L.H. Kuller, and A.C. Justice Hepatitis C virus infection and the risk of coronary disease Clin Infect Dis 49 2009 225 232
113. M.S. Freiberg, C.C. Chang, M. Skanderson, K. McGinnis, L.H. Kuller, and K.L. Kraemer The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C Circ Cardiovasc Qual Outcomes 4 2011 425 432
114. R. Bedimo, A.O. Westfall, M. Mugavero, H. Drechsler, N. Khanna, and M. Saag Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients HIV Med 11 2010 462 468
115. S. Maruyama, M. Koda, N. Oyake, H. Sato, Y. Fujii, and Y. Horie Myocardial injury in patients with chronic hepatitis C infection J Hepatol 58 2013 11 15
116. M.S. Lin, S.E. Guo, M.Y. Chen, T.J. Huang, J.C. Huang, and J.H. Hu The impact of hepatitis C infection on ischemic heart disease via ischemic electrocardiogram: a cross-sectional observational study Am J Med Sci 347 2014 478 484
117. C.C. Liao, T.C. Su, F.C. Sung, W.H. Chou, and T.L. Chen Does hepatitis C virus infection increase risk for stroke? A population-based cohort study PLoS One 7 2012 e31527
118. Z.M. Younossi, M. Stepanova, F. Nader, Z. Younossi, and E. Elsheikh Associations of chronic hepatitis C with metabolic and cardiac outcomes Aliment Pharmacol Ther 37 2013 647 652
119. M.H. Lee, H.I. Yang, C.H. Wang, C.L. Jen, S.H. Yeh, and C.J. Liu Hepatitis C virus infection and increased risk of cerebrovascular disease Stroke 41 2010 2894 2900
120. C.S. Hsu, J.H. Kao, Y.C. Chao, H.H. Lin, Y.C. Fan, and C.J. Huang Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan Aliment Pharmacol Ther 38 2013 415 423
121. J. Amin, M.G. Law, M. Bartlett, J.M. Kaldor, and G.J. Dore Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study Lancet 368 2006 938 945
122. A.M. Guiltinan, Z. Kaidarova, B. Custer, J. Orland, A. Strollo, and S. Cyrus Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors Am J Epidemiol 167 2008 743 750
123. S. Lai, H. Lai, Q. Meng, W. Tong, D. Vlahov, and D. Celentano Effect of cocaine use on coronary calcium among black adults in Baltimore, Maryland Am J Cardiol 90 2002 326 328
124. M.H. Lee, H.I. Yang, S.N. Lu, C.L. Jen, S.L. You, and L.Y. Wang Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study J Infect Dis 206 2012 469 477
125. M. Boddi, R. Abbate, B. Chellini, B. Giusti, V. Solazzo, and F. Soft HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques Dig Liver Dis 39 2007 S55 S60
126. N.F. Fletcher, G.K. Wilson, J. Murray, K. Hu, A. Lewis, and G.M. Reynolds Hepatitis C virus infects the endothelial cells of the blood-brain barrier Gastroenterology 142 2012 634 643
127. T. Roed, U.S. Kristoffersen, A. Knudsen, N. Wiinberg, A.M. Lebech, and T. Almdal Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C - A cross-sectional study Vasc Health Risk Manag 10 2014 55 62
128. H. Völzke, C. Schwahn, B. Wolff, R. Mentel, D.M. Robinson, and V. Kleine Hepatitis B and C virus infection and the risk of atherosclerosis in a general population Atherosclerosis 174 2004 99 103
129. C.M. Arcari, K.E. Nelson, D.M. Netski, F.J. Nieto, and C.A. Gaydos No association between hepatitis C virus seropositivity and acute myocardial infarction Clin Infect Dis 43 2006 e53 e56
130. F. Bilora, E. Campagnolo, R. Rinaldi, A. Rossato, M. Arzenton, and F. Petrobelli Carotid and femoral atherosclerosis in chronic hepatitis C: a 5-year follow-up Angiology 59 2008 717 720
131. M.G. Kristiansen, M.L. Løchen, T.J. Gutteberg, L. Mortensen, B.O. Eriksen, and J. Florholmen Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway J Viral Hepat 18 2011 237 244
132. K.A. Forde, K. Haynes, A.B. Troxel, S. Trooskin, M.T. Osterman, and S.E. Kimmel Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study J Viral Hepat 19 2012 271 277